Responding to Payor Policy Changes That Impact Patients with Postparalytic Facial Palsy: Chemodenervation with Botulinum Toxin
Facial Plast Surg Aesthet Med
.
2022 Sep-Oct;24(5):335-336.
doi: 10.1089/fpsam.2021.0372.
Epub 2022 Feb 1.
Authors
Matthew Q Miller
1
,
J Madison Clark
1
Affiliation
1
Department of Otolaryngology-Head and Neck Surgery, University of North Carolina Facial Nerve Center, Chapel Hill, North Carolina, USA.
PMID:
35104419
DOI:
10.1089/fpsam.2021.0372
No abstract available
MeSH terms
Botulinum Toxins, Type A* / therapeutic use
Facial Paralysis* / drug therapy
Humans
Nerve Block*
Neuromuscular Agents* / therapeutic use
Policy
Substances
Neuromuscular Agents
Botulinum Toxins, Type A